Arthur E. Bogdén

2.2k total citations
63 papers, 1.7k citations indexed

About

Arthur E. Bogdén is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Arthur E. Bogdén has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Immunology. Recurrent topics in Arthur E. Bogdén's work include Estrogen and related hormone effects (7 papers), Cancer Research and Treatments (5 papers) and Virus-based gene therapy research (4 papers). Arthur E. Bogdén is often cited by papers focused on Estrogen and related hormone effects (7 papers), Cancer Research and Treatments (5 papers) and Virus-based gene therapy research (4 papers). Arthur E. Bogdén collaborates with scholars based in United States, France and Slovakia. Arthur E. Bogdén's co-authors include Henry J. Esber, Harmar D. Brereton, Larry Norton, Richard Simon, William R. Cobb, John E. Taylor, Jacques-Pierre Moreau, Doreen LePage, David H. Coy and Thomas W. Griffin and has published in prestigious journals such as Nature, Science and Blood.

In The Last Decade

Arthur E. Bogdén

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur E. Bogdén United States 20 543 520 267 254 204 63 1.7k
M.J. O’Hare United Kingdom 28 1.2k 2.3× 512 1.0× 121 0.5× 99 0.4× 241 1.2× 62 2.5k
Yuko Ohnuki Japan 17 1.1k 2.0× 473 0.9× 242 0.9× 604 2.4× 315 1.5× 54 2.3k
J Uriel France 25 823 1.5× 231 0.4× 235 0.9× 94 0.4× 227 1.1× 83 1.9k
Noboru Kuzumaki Japan 26 1.3k 2.4× 682 1.3× 170 0.6× 343 1.4× 299 1.5× 123 2.4k
Michael J. Ahearn United States 16 858 1.6× 350 0.7× 106 0.4× 83 0.3× 156 0.8× 28 1.7k
G C Easty United Kingdom 23 549 1.0× 542 1.0× 81 0.3× 141 0.6× 251 1.2× 63 1.6k
I Taylor United States 19 1.6k 2.9× 553 1.1× 362 1.4× 335 1.3× 190 0.9× 40 2.9k
Gail A. Wong United States 14 1.1k 2.1× 307 0.6× 117 0.4× 109 0.4× 108 0.5× 20 1.7k
H F Kung United States 23 1.4k 2.6× 580 1.1× 171 0.6× 155 0.6× 204 1.0× 30 2.6k
Bernard N. Violand United States 18 951 1.8× 185 0.4× 97 0.4× 103 0.4× 201 1.0× 34 1.6k

Countries citing papers authored by Arthur E. Bogdén

Since Specialization
Citations

This map shows the geographic impact of Arthur E. Bogdén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur E. Bogdén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur E. Bogdén more than expected).

Fields of papers citing papers by Arthur E. Bogdén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur E. Bogdén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur E. Bogdén. The network helps show where Arthur E. Bogdén may publish in the future.

Co-authorship network of co-authors of Arthur E. Bogdén

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur E. Bogdén. A scholar is included among the top collaborators of Arthur E. Bogdén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur E. Bogdén. Arthur E. Bogdén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogdén, Arthur E., Jacques-Pierre Moreau, Christina Gamba‐Vitalo, et al.. (1998). Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF. International Journal of Cancer. 76(1). 38–46. 15 indexed citations
2.
Mahmoud, Soliman A., Julie K. Staley, John E. Taylor, et al.. (1991). [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.. PubMed. 51(7). 1798–802. 140 indexed citations
3.
Parmar, H., et al.. (1989). Somatostatin and somatostatin analogues in oncology. Cancer Treatment Reviews. 16(2). 95–115. 56 indexed citations
4.
Bogdén, Arthur E., William R. Cobb, & Doreen LePage. (1988). The 6-day subrenal capsule assay (SRCA): its criticism, biology and review of assay/clinical correlations.. PubMed. 276. 139–204. 1 indexed citations
5.
Taylor, John E., Arthur E. Bogdén, Jacques-Pierre Moreau, & David H. Coy. (1988). In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue. Biochemical and Biophysical Research Communications. 153(1). 81–86. 110 indexed citations
6.
Bogdén, Arthur E. & William R. Cobb. (1986). The subrenal capsule assay (SRCA). European Journal of Cancer and Clinical Oncology. 22(9). 1033–1036. 6 indexed citations
7.
Griffin, Thomas W., Arthur E. Bogdén, Donna Antonelli, et al.. (1983). Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer. 52(12). 2185–2192. 69 indexed citations
8.
Fleischman, Robert W., Gary C. du Moulin, Henry J. Esber, Vladimir Ilievski, & Arthur E. Bogdén. (1982). Nontuberculous mycobacterial infection attributable to Mycobacterium intracellulare serotype 10 in two rhesus monkeys. Journal of the American Veterinary Medical Association. 181(11). 1358–1362. 2 indexed citations
9.
Hartmann, Rolf W., et al.. (1981). Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes. Journal of Medicinal Chemistry. 24(10). 1192–1197. 18 indexed citations
10.
11.
Halberg, F, Warren O. Nelson, Françis Lévi, et al.. (1980). Chronotherapy of mammary cancer in rats.. PubMed. 7(2). 85–99. 9 indexed citations
12.
Ovejera, Artemio A., et al.. (1978). Therapy of mouse tumors and human tumor xenografts by the antitumor antibiotic at-125 (nsc-163501). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations
13.
Bogdén, Arthur E. & Henry J. Esber. (1978). Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 97–100. 4 indexed citations
14.
Bogdén, Arthur E., et al.. (1978). Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(1). 59–64. 19 indexed citations
15.
Cobb, William R., et al.. (1974). Effects of hysterectomy on milk secretion and serum levels of prolactin, growth hormone, estrogen, and progesterone in rhesus monkeys with hormone-induced uterine hypertrophy. American Journal of Obstetrics and Gynecology. 120(3). 368–375. 9 indexed citations
16.
Esber, Henry J., et al.. (1974). Variation in Serum Hormone Concentrations in Different Rat Strains. Experimental Biology and Medicine. 146(4). 1050–1053. 9 indexed citations
17.
Esber, Henry J., et al.. (1972). Nonspecific stimulation of tumor-associated immunity by methanol-soluble fraction of Mycobacterium butyricum.. PubMed. 32(4). 795–803. 5 indexed citations
18.
Esber, Henry J., et al.. (1970). Isolation of an acute phase α2-glycoprotein from rat inflammatory serum. Clinica Chimica Acta. 27(3). 385–394. 12 indexed citations
19.
Bogdén, Arthur E., et al.. (1961). Immunogenetic Studies of a Histocompatibility Hemagglutinogen (R-1) in the Rat<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 3 indexed citations
20.
Bogdén, Arthur E., et al.. (1960). The R-1 Factor, a Histocompatibility Antigen in the Rat. Cancer Research. 20(9). 1372–1382. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.J. O’Hare Breakdown of academic impact, for papers by Yuko Ohnuki Breakdown of academic impact, for papers by J Uriel Breakdown of academic impact, for papers by Noboru Kuzumaki Breakdown of academic impact, for papers by Michael J. Ahearn Breakdown of academic impact, for papers by G C Easty Breakdown of academic impact, for papers by I Taylor Breakdown of academic impact, for papers by Gail A. Wong Breakdown of academic impact, for papers by H F Kung Breakdown of academic impact, for papers by Bernard N. Violand
Rankless by CCL
2026